Claudia Ardino was born in Bari, Italy. She received her MSc in Chemistry and Pharmaceutical Technologies at the University of Bari Aldo Moro, in 2017. During her master studies she worked on the synthesis of mannich bases derived from tetrahydroazepino moieties as selective BuChE inhibitors to treat Alzheimer’s disease. After graduation, in 2018, Claudia attended a second level professional master programme in Drug Design and Synthesis at the University of Siena where she joined the group of Maurizio Botta, working on the synthesis of novel broad-spectrum antivirals targeting enveloped viruses. Later in the same year, she started her PhD in Chemical and Pharmaceutical Sciences, under the supervision of Prof. Maurizio Botta and then Prof. Elena Petricci. During her doctoral research she worked on the synthesis of polyalkylguanidino ureas endowed with promising antibacterial activity. Founded by an Erasmus+ grant, Claudia joined the group of Prof. Timothy Noël at the University of Amsterdam in June 2021 as visiting PhD student, where she is currently working on the merging of HAT processes and photocatalysis.